How to administer injection albumin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Administer Injection Albumin

Albumin should be administered intravenously, with the rate and dose tailored to the clinical indication, patient's condition, and risk of volume overload. 1

Administration Technique

  • Albumin should always be administered by intravenous infusion, either undiluted or diluted in 0.9% Sodium Chloride or 5% Dextrose in Water 1
  • If sodium restriction is required, albumin should only be administered either undiluted or diluted in a sodium-free carbohydrate solution such as 5% Dextrose in Water 1
  • Before administration, remove the seal to expose the stopper and swab with a suitable antiseptic 1
  • Use 16 gauge needles or dispensing pins with 20 mL vial sizes and larger, inserting them perpendicular to the plane of the stopper within the designated ring area 1
  • Visually inspect the solution for particulate matter and discoloration prior to administration 1

Dosing Guidelines Based on Indication

Congenital Nephrotic Syndrome

  • Base albumin infusion on clinical indicators of hypovolaemia (prolonged capillary refill time, tachycardia, hypotension, oliguria, abdominal discomfort) rather than serum albumin levels 2
  • For patients with severe disease, daily albumin infusions of 1–4 g/kg may be initiated 2
  • Consider administering a dose of furosemide (0.5–2 mg/kg) at the end of each albumin infusion, unless the patient has marked hypovolaemia and/or hyponatraemia 2

Liver Disease/Cirrhosis

  • For large volume paracentesis (>5L), administer albumin at a dose of 8g per liter of ascites removed after the procedure is completed 2
  • For spontaneous bacterial peritonitis, administer 1.5 g/kg on day 1 and 1 g/kg on day 3 2
  • For hepatorenal syndrome, administer albumin with vasoactive drugs 3

Hypovolemic Shock

  • Adapt volume and infusion speed to the individual patient's response 1
  • Monitor for signs of circulatory overload 1

Burns

  • Aim to maintain plasma albumin concentration around 2.5 ± 0.5 g per 100 mL 1
  • Duration of therapy is determined by protein loss from burned areas and in urine 1

Hypoproteinemia

  • Usual daily dose is 50 to 75 g for adults and 25 g for children 1
  • Do not exceed administration rate of 2 mL per minute to avoid circulatory embarrassment and pulmonary edema 1

Infusion Rate Considerations

  • In patients with normal blood volume, administer slowly to prevent circulatory overload 1
  • For hypoproteinemic patients, do not exceed 2 mL per minute 1
  • For furosemide administered with albumin, infuse over 5–30 minutes to minimize ototoxicity 2

Monitoring During Administration

  • Always monitor patients carefully to guard against circulatory overload 1
  • In dehydrated patients, albumin must be given with or followed by additional fluids 1
  • Monitor fluid status, electrolytes, blood pressure, and kidney function during administration 2
  • For patients receiving regular albumin infusions via central venous lines, consider prophylactic anticoagulation 2

Special Considerations

  • Albumin is compatible with whole blood, packed red cells, and standard carbohydrate and electrolyte solutions 1
  • Do not mix with protein hydrolysates, amino acid solutions, or solutions containing alcohol 1
  • In hemorrhage, supplement albumin administration with whole blood transfusion to treat relative anemia associated with hemodilution 1
  • Home administration of albumin by trained caregivers is feasible and safe for selected patients requiring long-term therapy 2, 4

Potential Adverse Effects

  • Circulatory overload, particularly in patients with cardiac or renal insufficiency 1
  • Rapid blood pressure elevation requiring careful observation for bleeding from previously undetected vessels 1
  • Pulmonary edema if administered too rapidly 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Albumin: a comprehensive review and practical guideline for clinical use.

European journal of clinical pharmacology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.